Dr. Ignatius is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5501 Hopkins Bayview Circle
Allergy & Asthma Center, 2nd Floor
Baltimore, MD 21224Phone+1 410-550-5864Fax+1 410-367-2376
Education & Training
- Emory University School of MedicineResidency, Internal Medicine, 2013 - 2016
- Emory University School of MedicineClass of 2013
Certifications & Licensure
- MD State Medical License 2018 - 2026
- VA State Medical License 2023 - 2026
- GA State Medical License 2016 - 2017
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 1 citationsHigh-Dose Isoniazid Lacks EARLY Bactericidal Activity against Isoniazid-resistant Tuberculosis Mediated by katG Mutations: A Randomized Phase II Clinical Trial.Kamunkhwala Gausi, Elisa H Ignatius, Veronique De Jager, Caryn Upton, Soyeon Kim
American Journal of Respiratory and Critical Care Medicine. 2024-08-01 - 1 citationsEfficacies of omadacycline + amikacin + imipenem and an all-oral regimen omadacycline + clofazimine + linezolid in a mouse model oflung disease.Elisa H Ignatius, Binayak Rimal, Chandra M Panthi, Daniel C Belz, Christopher K Lippincott
Msphere. 2024-07-30 - 4 citationsEfficacies of three drug regimens containing omadacycline to treat Mycobacteroides abscessus disease.Binayak Rimal, Chandra M Panthi, Yi Xie, Daniel C Belz, Elisa H Ignatius
Tuberculosis. 2024-05-01
Press Mentions
- We Asked an Infectious Disease Doctor About Coronavirus. Here’s What She SaidFebruary 27th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: